Home Amylgen

Amylgen

In operation
-
Pharmaceutical and Health Product R&D Providers

Basic Information

Amylgen is a CRO that proposes innovative in vivo models targeting aging, psychiatric disorders, and neurodegenerative diseases for the development of new drugs or nutraceuticals. Amylgen can provide rapid POC for your product as a brain health food supplement and help confirm your product's efficacy through preclinical studies in rodent models.
Amylgen
France
less than 15 people
January 01, 2009
--